Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

PR Newswire July 6, 2023

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

PR Newswire June 28, 2023

Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023

PR Newswire June 22, 2023

Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation

PR Newswire June 21, 2023

Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest

PR Newswire June 14, 2023

Aethlon Medical to Present at the 13th Annual LD Micro Invitational

PR Newswire June 1, 2023

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

PR Newswire May 22, 2023

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

PR Newswire February 13, 2023

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023

PR Newswire February 6, 2023

Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

PR Newswire January 31, 2023

Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer

PR Newswire January 30, 2023

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

PR Newswire November 14, 2022

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022

PR Newswire November 2, 2022

Aethlon Medical to Present at Two Investor Conferences in September

PR Newswire September 6, 2022

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

PR Newswire August 9, 2022

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

PR Newswire August 3, 2022

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

PR Newswire July 28, 2022

Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment

PR Newswire July 11, 2022

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

PR Newswire June 28, 2022

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022

PR Newswire June 21, 2022